Quarterly report [Sections 13 or 15(d)]

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT)

v3.25.2
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT) - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Treasury Stock
Paid-in Capital
Accumulated Other Comprehensive Loss, net of tax
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2023   20,449        
Beginning balance at Dec. 31, 2023 $ (20,442) $ 20 $ (174,702) $ 229,680 $ (22) $ (75,418)
Beginning balance (in shares) at Dec. 31, 2023     4,921      
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of restricted stock, shares exchanged for exercise and tax, and stock issued through employee stock purchase plan (in shares)     (84)      
Issuance of restricted stock, shares exchanged for exercise and tax, and stock issued through employee stock purchase plan (371)   $ 3,011 (3,382)    
Non-cash stock compensation 1,190     1,190    
Net income (loss) (9,460)         (9,460)
Other comprehensive income (loss), net of tax (18)       (18)  
Ending balance (in shares) at Apr. 21, 2024   20,449        
Ending balance at Apr. 21, 2024 (29,101) $ 20 $ (171,691) 227,488 (40) (84,878)
Ending balance (in shares) at Apr. 21, 2024     4,837      
Beginning balance (in shares) at Dec. 31, 2023   20,449        
Beginning balance at Dec. 31, 2023 (20,442) $ 20 $ (174,702) 229,680 (22) (75,418)
Beginning balance (in shares) at Dec. 31, 2023     4,921      
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) (18,949)          
Other comprehensive income (loss), net of tax (14)          
Ending balance (in shares) at Jul. 14, 2024   20,449        
Ending balance at Jul. 14, 2024 (36,543) $ 20 $ (166,585) 224,425 (36) (94,367)
Ending balance (in shares) at Jul. 14, 2024     4,694      
Beginning balance (in shares) at Apr. 21, 2024   20,449        
Beginning balance at Apr. 21, 2024 (29,101) $ 20 $ (171,691) 227,488 (40) (84,878)
Beginning balance (in shares) at Apr. 21, 2024     4,837      
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of restricted stock, shares exchanged for exercise and tax, and stock issued through employee stock purchase plan (in shares)     (143)      
Issuance of restricted stock, shares exchanged for exercise and tax, and stock issued through employee stock purchase plan 187   $ 5,106 (4,919)    
Non-cash stock compensation 1,856     1,856    
Net income (loss) (9,489)         (9,489)
Other comprehensive income (loss), net of tax 4       4  
Ending balance (in shares) at Jul. 14, 2024   20,449        
Ending balance at Jul. 14, 2024 $ (36,543) $ 20 $ (166,585) 224,425 (36) (94,367)
Ending balance (in shares) at Jul. 14, 2024     4,694      
Beginning balance (in shares) at Dec. 29, 2024 17,403 22,050        
Beginning balance at Dec. 29, 2024 $ (84,269) $ 22 $ (164,937) 233,667 (62) (152,959)
Beginning balance (in shares) at Dec. 29, 2024 4,647   4,647      
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of restricted stock, shares exchanged for exercise and tax, and stock issued through employee stock purchase plan (in shares)     (335)      
Issuance of restricted stock, shares exchanged for exercise and tax, and stock issued through employee stock purchase plan $ 241   $ 11,993 (11,752)    
Non-cash stock compensation 2,365     2,365    
Net income (loss) 1,249         1,249
Other comprehensive income (loss), net of tax 2       2  
Ending balance (in shares) at Apr. 20, 2025   22,050        
Ending balance at Apr. 20, 2025 $ (80,412) $ 22 $ (152,944) 224,280 (60) (151,710)
Ending balance (in shares) at Apr. 20, 2025     4,312      
Beginning balance (in shares) at Dec. 29, 2024 17,403 22,050        
Beginning balance at Dec. 29, 2024 $ (84,269) $ 22 $ (164,937) 233,667 (62) (152,959)
Beginning balance (in shares) at Dec. 29, 2024 4,647   4,647      
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) $ 5,242          
Other comprehensive income (loss), net of tax $ 2          
Ending balance (in shares) at Jul. 13, 2025 17,886 22,050        
Ending balance at Jul. 13, 2025 $ (78,643) $ 22 $ (147,645) 216,757 (60) (147,717)
Ending balance (in shares) at Jul. 13, 2025 4,164   4,164      
Beginning balance (in shares) at Apr. 20, 2025   22,050        
Beginning balance at Apr. 20, 2025 $ (80,412) $ 22 $ (152,944) 224,280 (60) (151,710)
Beginning balance (in shares) at Apr. 20, 2025     4,312      
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of restricted stock, shares exchanged for exercise and tax, and stock issued through employee stock purchase plan (in shares)     (148)      
Issuance of restricted stock, shares exchanged for exercise and tax, and stock issued through employee stock purchase plan 230   $ 5,299 (5,069)    
Non-cash stock compensation (2,454)     (2,454)    
Net income (loss) 3,993         3,993
Other comprehensive income (loss), net of tax $ 0          
Ending balance (in shares) at Jul. 13, 2025 17,886 22,050        
Ending balance at Jul. 13, 2025 $ (78,643) $ 22 $ (147,645) $ 216,757 $ (60) $ (147,717)
Ending balance (in shares) at Jul. 13, 2025 4,164   4,164